Yunsheng He - Concepedia

Author

Yunsheng He

Novartis (United States)ORCID

Also Known As

He Yun-Sheng, He, Yunsheng, Yunsheng He

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Novartis (Switzerland)McGill University Tris Pharma (United States)Harvard University

About

Yunsheng He is an author at Novartis (United States) specializing in medicine, cardiovascular genetics, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	389
2	Health Sciences	1	1	36
3	Natural Sciences	1	1	158
4	Social Sciences	1	1	335
5	Biochemistry	1	1	158

Yunsheng He

Publications

Citations

H-Index

Page 1

	Year	Citations
Epigenetic Modification of the <i>FMR1</i> Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056 Sébastien Jacquemont, Aurore Curie, Vincent des Portes, Science Translational Medicine	2011	610
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study Howard Feldman, Steven H. Ferris, Bengt Winblad, The Lancet Neurology NeuropsychologyAlzheimer's DiseaseAgingVascular Cognitive DisorderDementia	2007	335
<i>TET2</i>-Driven Clonal Hematopoiesis and Response to Canakinumab E. C. Svensson, Aviv Madar, Catarina D. Campbell, JAMA Cardiology	2022	333
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period Roger Bullock, Jacques Touchon, Howard Bergman, Current Medical Research and Opinion	2005	230
An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets Brian K. Kay, Nils B. Adey, Yunsheng He, Gene M13 Phage LibraryNovel SequencesBiochemistryProtein FoldingNatural Sciences	1993	158
Protein synthesis levels are increased in a subset of individuals with fragile X syndrome Sébastien Jacquemont, Laura Pacini, Aia Elise Jønch, Human Molecular Genetics	2018	70
Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease Rafael Blesa, Roger Bullock, Yunsheng He, Pharmacogenetics and Genomics	2006	65
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease Roger Bullock, Howard Bergman, Jacques Touchon, Current Medical Research and Opinion	2006	63
Synergistic effect of apolipoprotein E ε4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease Roger Lane, Howard Feldman, Joanne M. Meyer, Pharmacogenetics and Genomics	2008	60
BuChE‐K and APOE ϵ4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline Roger Lane, Yunsheng He, Christopher M. Morris, Movement Disorders	2008	41

Page 1